Stellantis Turnaround Plan Prediction Market Regulation and Ouras IPO Filing Highlight Morning Market Movers Qualcomm Faces Persistent Short Seller Pressure as AI Pivot Becomes Critical for Bulls Analysts Suggest MegaIPOs From SpaceX and OpenAI May Signal Market Peak as Record Listings Loom Global Markets Rally on AI Boom Indian Equities Face Headwinds From Geopolitics and Oil Pondy Oxides Chemicals Invests 200 Crore in New Copper Recycling Plant in Tamil Nadu Europes AI Trade Dependency Could Pose Strategic Risks Report Warns HAFC Q1 2026 Earnings EPS Beats Estimates by 478 Amid Challenging Banking Environment NGG Q1 2026 Earnings EPS Falls Short of Estimates as Utility Giants Shares Edge Higher RWAY Q1 2026 Earnings EPS Falls Short of Analyst Expectations QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress TIC Solutions Inc Q1 2026 Earnings Deep EPS Miss Highlights Ongoing Cost Pressures ABT Q1 2026 Earnings EPS Falls Slightly Short of Estimates Shares Edge Lower Cohen Steers LDP Holds Steady Near Support Amid Preferred Income Stability GIBO Holdings GIBO Edges Higher Key Support and Resistance Levels in Focus Alumis Inc ALMS Edges Lower Consolidating Above Key Support Level Axcelis Technologies Edges Higher Amid Support Resistance Looms Gesher Acquisition Corp II Warrants GSHRW Rallies 949 as Price Approaches Resistance at 025 BCG Global Wealth Report 2026 Germanys UltraRich Hold Over a Quarter of Financial Wealth Inequality Widens Chunghwa Telecom Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Gladstone Commercial GOOD Tests Key Support After 155 Decline Cheetah Mobile CMCM Q4 2025 Earnings Loss Per ADS of 110 Stock Declines 35 SLDE Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline VSEC Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction ASR Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Headwinds Gladstone Land Corporation LANDP Q1 2026 Earnings Preferred Shares Beat Estimates Despite Negative EPS AVR Q1 2026 Earnings Wider Than Expected Losses as PreRevenue Biotech Advances ADTN Q1 2026 Earnings EPS Beats Estimates by 47 but Stock Falls 139